Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2024-09-27 00:00:00 ET · period of report 2024-09-25 · accession 0001453687-24-000112 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-27 | 2024-09-25 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | M - OptEx | — | 0 | 6.02M | New | — |
| MI | 2024-09-27 | 2024-09-25 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | M - OptEx | — | 0 | 12.8K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series B Non-Voting Convertible Preferred Stock | 2024-09-25 | M | D | 1,636,832 | — | 0 | D See Footnote | — | — | (F1) On September 20, 2024, the issuer held a special meeting of stockholders (the "Special Meeting"). At the Special Meeting, the stockholders of the issuer approved the conversion of the issuer's Series B Non-Voting Convertible Preferred Stock ("Series B Preferred Stock") into shares of common stock. On September 25, 2024, the conversion of the majority of the shares of Series B Preferred Stock occurred automatically (the "Automatic Conversion"). The remaining shares of Series B Preferred Stock remain subject to certain beneficial ownership limitations described in the issuer's filings with the Securities and Exchange Commission. At the time of the Automatic Conversion, all of the shares of Series B Preferred Stock beneficially owned by the reporting person converted into shares of common stock. (F2) Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any. |
| 2 | Common | Common Stock | 2024-09-25 | M | A | 1,636,832 | — | 6,016,731 | D See Footnote | — | — | (F1) On September 20, 2024, the issuer held a special meeting of stockholders (the "Special Meeting"). At the Special Meeting, the stockholders of the issuer approved the conversion of the issuer's Series B Non-Voting Convertible Preferred Stock ("Series B Preferred Stock") into shares of common stock. On September 25, 2024, the conversion of the majority of the shares of Series B Preferred Stock occurred automatically (the "Automatic Conversion"). The remaining shares of Series B Preferred Stock remain subject to certain beneficial ownership limitations described in the issuer's filings with the Securities and Exchange Commission. At the time of the Automatic Conversion, all of the shares of Series B Preferred Stock beneficially owned by the reporting person converted into shares of common stock. (F2) Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any. |
| 3 | Common | Series B Non-Voting Convertible Preferred Stock | 2024-09-25 | M | D | 721,361 | — | 0 | I By wife | — | — | (F1) On September 20, 2024, the issuer held a special meeting of stockholders (the "Special Meeting"). At the Special Meeting, the stockholders of the issuer approved the conversion of the issuer's Series B Non-Voting Convertible Preferred Stock ("Series B Preferred Stock") into shares of common stock. On September 25, 2024, the conversion of the majority of the shares of Series B Preferred Stock occurred automatically (the "Automatic Conversion"). The remaining shares of Series B Preferred Stock remain subject to certain beneficial ownership limitations described in the issuer's filings with the Securities and Exchange Commission. At the time of the Automatic Conversion, all of the shares of Series B Preferred Stock beneficially owned by the reporting person converted into shares of common stock. |
| 4 | Common | Common Stock | 2024-09-25 | M | A | 721,361 | — | 2,648,991 | I By wife | — | — | (F1) On September 20, 2024, the issuer held a special meeting of stockholders (the "Special Meeting"). At the Special Meeting, the stockholders of the issuer approved the conversion of the issuer's Series B Non-Voting Convertible Preferred Stock ("Series B Preferred Stock") into shares of common stock. On September 25, 2024, the conversion of the majority of the shares of Series B Preferred Stock occurred automatically (the "Automatic Conversion"). The remaining shares of Series B Preferred Stock remain subject to certain beneficial ownership limitations described in the issuer's filings with the Securities and Exchange Commission. At the time of the Automatic Conversion, all of the shares of Series B Preferred Stock beneficially owned by the reporting person converted into shares of common stock. |
| 5 | Common | Series B Non-Voting Convertible Preferred Stock | 2024-09-25 | M | D | 1,307 | — | 0 | I | — | — | (F1) On September 20, 2024, the issuer held a special meeting of stockholders (the "Special Meeting"). At the Special Meeting, the stockholders of the issuer approved the conversion of the issuer's Series B Non-Voting Convertible Preferred Stock ("Series B Preferred Stock") into shares of common stock. On September 25, 2024, the conversion of the majority of the shares of Series B Preferred Stock occurred automatically (the "Automatic Conversion"). The remaining shares of Series B Preferred Stock remain subject to certain beneficial ownership limitations described in the issuer's filings with the Securities and Exchange Commission. At the time of the Automatic Conversion, all of the shares of Series B Preferred Stock beneficially owned by the reporting person converted into shares of common stock. |
| 6 | Common | Common Stock | 2024-09-25 | M | A | 1,307 | — | 12,816 | I | — | — | (F1) On September 20, 2024, the issuer held a special meeting of stockholders (the "Special Meeting"). At the Special Meeting, the stockholders of the issuer approved the conversion of the issuer's Series B Non-Voting Convertible Preferred Stock ("Series B Preferred Stock") into shares of common stock. On September 25, 2024, the conversion of the majority of the shares of Series B Preferred Stock occurred automatically (the "Automatic Conversion"). The remaining shares of Series B Preferred Stock remain subject to certain beneficial ownership limitations described in the issuer's filings with the Securities and Exchange Commission. At the time of the Automatic Conversion, all of the shares of Series B Preferred Stock beneficially owned by the reporting person converted into shares of common stock. |